A comparison of intravaginal misoprostol with extraamniotic ethacridine lactate for second trimester MTP

被引:0
|
作者
Snehamay, Chaudhuri [1 ]
Nath, Mitra Sankar [1 ]
Nilanjana, Chaudhuri [1 ]
Debasish, Chattopadhya [1 ]
Debdut, Banerjee [1 ]
Sudipta, Bose [1 ]
机构
[1] NRS Med Coll, Dept Gynecol & Obstet, Kolkata 700014, India
来源
关键词
voluntary termination of midtrimester pregnancy; ethacridine lactate; vaginal misoprostol;
D O I
暂无
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
OBJECTIVE(S) : To compare safety, efficacy, complications, and cost effectiveness of extraamniotic instillation of ethacridine lactate with vaginal misoprostol for voluntary termination of second trimester pregnancy. METHOD(S) : A prospective comparative study on 120 pregnant women between 13 and 20 weeks was conducted from July 2004 to June 2005. Women were randomized in two groups. In one group extraamniotic ethacridine lactate (10mL/week of gestation) instillation was done and in the other, 400 ? g tablet of misoprostol was inserted in the vagina every 12 hours for a maximum of 4 doses. RESULTS : The rate of successful abortions within 48 hours was 95% (57/60 women) in each group. Among those who had aborted within 48 hours, the mean interval from induction to abortion was shorter in misoprostol group (15.5 hours vs 31.3 hours, P<0.0001). The rate of complete abortion, defined as expulsion of both fetus and placenta without operative assistance, was 66.6% for misoprostol and 70% for ethacridine lactate (P=0.344). The average cost per treatment was Rs. 57.95 for misoprostol as compared to Rs. 86.10 for ethacridine lactate. Side effects were uncommon and did not differ between the two groups. CONCLUSION(S) : Success rates of misoprostol and ethacridine lactate were comparable but the induction abortion interval was almost half in misoprostol group when compared with that in ethacridine lactate group.
引用
收藏
页码:518 / 521
页数:4
相关论文
共 50 条
  • [21] Separation of cesarean scar during second-trimester intravaginal misoprostol abortion
    Chen, M
    Shih, JC
    Chiu, WT
    Hsieh, FJ
    OBSTETRICS AND GYNECOLOGY, 1999, 94 (05): : 840 - 840
  • [22] Efficacy and safety of intravaginal followed by sublingual misoprostol for second trimester pregnancy termination
    Tripti, Nagaria
    Swati, Somawar
    JOURNAL OF OBSTETRICS AND GYNECOLOGY OF INDIA, 2007, 57 (05): : 403 - 406
  • [23] The optimization of intravaginal misoprostol dosing schedules in second-trimester pregnancy termination
    Dickinson, JE
    Evans, SF
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2002, 186 (03) : 470 - 474
  • [24] Comparative study of intravaginal misoprostol with gemeprost as an abortifacient in second trimester missed abortion
    Eng, NS
    Guan, AC
    AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY, 1997, 37 (03): : 331 - 334
  • [25] Comparing two regimens of intravaginal misoprostol with intravaginal gemeprost for second-trimester pregnancy termination: a randomised controlled trial
    Koh, Daniel Seow Choon
    Ang, Esther Pei Jing
    Coyuco, Jurja Chua
    Teo, Hua Zhen
    Huang, Xiaoling
    Wei, Xing
    Ng, Mor Jack
    Lim, Serene Liqing
    Tan, Kok Hian
    JOURNAL OF FAMILY PLANNING AND REPRODUCTIVE HEALTH CARE, 2017, 43 (04): : 252 - 259
  • [26] Termination of second-trimester pregnancy by mifepristone combined with misoprostol versus intra-amniotic injection of ethacridine lactate (Rivanol®): a systematic review of Chinese trials
    Hou, Shu-Ping
    Fang, Ai-Hua
    Chen, Qin-Fang
    Huang, Yong-Mei
    Chen, Oiu-ju
    Cheng, Li-Nan
    CONTRACEPTION, 2011, 84 (03) : 214 - 223
  • [27] Intraamniotic ethacridine lactate instillation versus vaginal PGE1 in second trimester termination of pregnancy
    Berg, Christoph
    Ludwig, Michael
    Sturm, Nina
    Diedrich, Klaus
    Gembruch, Ulrich
    Geipel, Annegret
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2006, 126 (02) : 193 - 196
  • [28] Mifepristone combined with misoprostol versus intra-amniotic injection of ethacridine lactate for the termination of second trimester pregnancy: a prospective, open-label, randomized clinical trial
    Hou, Shuping
    Chen, Qinfang
    Zhang, Lanrong
    Fang, Aihua
    Cheng, Linan
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2010, 151 (02) : 149 - 153
  • [29] Cardiovascular effects of intravaginal misoprostol in the mid trimester of pregnancy
    Ramsey, PS
    Hogg, BB
    Savage, KG
    Winkler, DD
    Owen, J
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2000, 183 (05) : 1100 - 1102
  • [30] A prospective, randomised comparative study of second trimester termination of pregnancy (TOP) using mifepristone with intravaginal misoprostol and prostaglandin E2 gel with intravaginal misoprostol
    Tanwar, M.
    Zutshi, V
    Shamsunder, S.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2014, 121 : 6 - 6